{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:24:54Z","timestamp":1767824694520,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T00:00:00Z","timestamp":1275523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00330-010-1819-2","type":"journal-article","created":{"date-parts":[[2010,6,2]],"date-time":"2010-06-02T08:38:58Z","timestamp":1275467938000},"page":"2496-2502","source":"Crossref","is-referenced-by-count":63,"title":["Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas"],"prefix":"10.1007","volume":"20","author":[{"given":"Michail","family":"Plotkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Blechschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Auf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Nyuyki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Geworski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Denecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Stockhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,3]]},"reference":[{"key":"1819_CR1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1212\/WNL.41.11.1741","volume":"41","author":"MJ Glantz","year":"1991","unstructured":"Glantz MJ, Burger PC, Herndon JE, Friedman AH, Cairncross JG, Vick NA, Schold SC Jr (1991) Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 41:1741\u20131744","journal-title":"Neurology"},{"key":"1819_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01400714","volume":"124","author":"JM Brucher","year":"1993","unstructured":"Brucher JM (1993) Neuropathological diagnosis with stereotactic biopsies. Possibilities, difficulties and requirements. Acta Neurochir 124:37\u201339","journal-title":"Acta Neurochir"},{"key":"1819_CR3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJM200101113440207","volume":"344","author":"LM DeAngelis","year":"2001","unstructured":"DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114\u2013123","journal-title":"N Engl J Med"},{"key":"1819_CR4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00598951","volume":"34","author":"M Watanabe","year":"1992","unstructured":"Watanabe M, Tanaka R, Takeda N (1992) Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34:463\u2013469","journal-title":"Neuroradiology"},{"key":"1819_CR5","first-page":"162","volume":"21","author":"TN Byrne","year":"1994","unstructured":"Byrne TN (1994) Imaging of gliomas. Semin Oncol 21:162\u2013171","journal-title":"Semin Oncol"},{"key":"1819_CR6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0090-3019(97)00360-1","volume":"49","author":"LE Ginsberg","year":"1998","unstructured":"Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF (1998) The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 49:436\u2013440","journal-title":"Surg Neurol"},{"key":"1819_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3171\/jns.1993.79.4.0533","volume":"79","author":"D Kondziolka","year":"1993","unstructured":"Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533\u2013536","journal-title":"J Neurosurg"},{"key":"1819_CR8","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/(SICI)1097-0142(19970901)80:5<936::AID-CNCR15>3.0.CO;2-X","volume":"80","author":"FG Barker 2nd","year":"1997","unstructured":"Barker FG 2nd, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott MW, Wilson CB, Prados MD (1997) Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 80:936\u2013941","journal-title":"Cancer"},{"key":"1819_CR9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1212\/WNL.59.6.947","volume":"59","author":"JN Scott","year":"2002","unstructured":"Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947\u2013949","journal-title":"Neurology"},{"key":"1819_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/00006123-198901000-00001","volume":"24","author":"TL Francavilla","year":"1989","unstructured":"Francavilla TL, Miletich RS, Di Chiro G, Patronas NJ, Rizzoli HV, Wright DC (1989) Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery 24:1\u20135","journal-title":"Neurosurgery"},{"key":"1819_CR11","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1098::AID-CNCR21>3.0.CO;2-X","volume":"78","author":"S Goldman","year":"1996","unstructured":"Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Stanus E, Brotchi J, Hildebrand J (1996) Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer 78:1098\u20131106","journal-title":"Cancer"},{"key":"1819_CR12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3171\/jns.1993.79.6.0853","volume":"79","author":"K Herholz","year":"1993","unstructured":"Herholz K, Pietrzyk U, Voges J, Schroder R, Halber M, Treuer H, Sturm V, Heiss WD (1993) Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg 79:853\u2013858","journal-title":"J Neurosurg"},{"key":"1819_CR13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1052-5149(02)00033-3","volume":"12","author":"TZ Wong","year":"2002","unstructured":"Wong TZ, van der Westhuizen GJ, Coleman RE (2002) Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 12:615\u2013626","journal-title":"Neuroimaging Clin N Am"},{"key":"1819_CR14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00259-001-0690-4","volume":"29","author":"JK Chung","year":"2002","unstructured":"Chung JK, Kim YK, Kim SK, Lee YJ, Paek S, Yeo JS, Jeong JM, Lee DS, Jung HW, Lee MC (2002) Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG-PET. Eur J Nucl Med Mol Imaging 29:176\u2013182","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1819_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiology.195.1.7892494","volume":"195","author":"D Delbeke","year":"1995","unstructured":"Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47\u201352","journal-title":"Radiology"},{"key":"1819_CR16","first-page":"1653","volume":"45","author":"AM Spence","year":"2004","unstructured":"Spence AM, Muzi M, Mankoff DA, O'Sullivan SF, Link JM, Lewellen TK, Lewellen B, Pham P, Minoshima S, Swanson K, Krohn KA (2004) 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. J Nucl Med 45:1653\u20131659","journal-title":"J Nucl Med"},{"key":"1819_CR17","first-page":"1104","volume":"35","author":"K Ishizu","year":"1994","unstructured":"Ishizu K, Nishizawa S, Yonekura Y, Sadato N, Magata Y, Tamaki N, Tsuchida T, Okazawa H, Miyatake S, Ishikawa M et al (1994) Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med 35:1104\u20131109","journal-title":"J Nucl Med"},{"key":"1819_CR18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3171\/jns.2007.106.4.633","volume":"106","author":"F Stockhammer","year":"2007","unstructured":"Stockhammer F, Thomale UW, Plotkin M, Hartmann C, von Deimling A (2007) 18F-fluorodeoxyglucose uptake is associated with 1p and 19q loss in WHO grade II gliomas. J Neurosurg 106:633\u2013637","journal-title":"J Neurosurg"},{"key":"1819_CR19","first-page":"1146","volume":"45","author":"M Levivier","year":"2004","unstructured":"Levivier M, Massager N, Wikler D, Lorenzoni J, Ruiz S, Devriendt D, David P, Desmedt F, Simon S, Van Houtte P, Brotchi J, Goldman S (2004) Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. J Nucl Med 45:1146\u20131154","journal-title":"J Nucl Med"},{"key":"1819_CR20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3171\/jns.2004.101.3.0476","volume":"101","author":"B Pirotte","year":"2004","unstructured":"Pirotte B, Goldman S, Massager N, David P, Wikler D, Lipszyc M, Salmon I, Brotchi J, Levivier M (2004) Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. J Neurosurg 101:476\u2013483","journal-title":"J Neurosurg"},{"key":"1819_CR21","first-page":"1459","volume":"38","author":"S Goldman","year":"1997","unstructured":"Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Dethy S, Brotchi J, Hildebrand J (1997) Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. J Nucl Med 38:1459\u20131462","journal-title":"J Nucl Med"},{"key":"1819_CR22","first-page":"1293","volume":"45","author":"B Pirotte","year":"2004","unstructured":"Pirotte B, Goldman S, Massager N, David P, Wikler D, Vandesteene A, Salmon I, Brotchi J, Levivier M (2004) Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 45:1293\u20131298","journal-title":"J Nucl Med"},{"key":"1819_CR23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awh399","volume":"128","author":"D Pauleit","year":"2005","unstructured":"Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, M\u00fcller HW, Zilles K, Coenen HH, Langen KJ (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128:678\u2013687","journal-title":"Brain"},{"key":"1819_CR24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nucmedbio.2006.01.002","volume":"33","author":"KJ Langen","year":"2006","unstructured":"Langen KJ, Hamacher K, Weckesser M, Floeth F, Stoffels G, Bauer D, Coenen HH, Pauleit D (2006) O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 33:287\u2013294","journal-title":"Nucl Med Biol"},{"key":"1819_CR25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s002590050541","volume":"27","author":"W Weber","year":"2000","unstructured":"Weber W, Wester HJ, Grosu AL, Herz M, Dzewas B, Feldmann HJ, Molls M, Stocklin G, Schwaiger M (2000) O-(2-[18F] fluoroethyl)-L-tyrosine and L-[methyl-11C] methionine uptake in brain tumours: Initial results of a comparative study. Eur J Nucl Med 27:542\u2013549","journal-title":"Eur J Nucl Med"},{"key":"1819_CR26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.nucmedbio.2009.05.005","volume":"36","author":"D Pauleit","year":"2009","unstructured":"Pauleit D, Stoffels G, Bachofner A, Floeth FW, Sabel M, Herzog H, Tellmann L, Jansen P, Reifenberger G, Hamacher K, Coenen HH, Langen KJ (2009) Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. Nucl Med Biol 36:779\u2013787","journal-title":"Nucl Med Biol"},{"key":"1819_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000103262","volume":"85","author":"H Bjartmarz","year":"2007","unstructured":"Bjartmarz H, Rehncrona S (2007) Comparison of accuracy and precision between frame- based and frameless stereotactic navigation for deep brain stimulation electrode implantation. Stereotact Funct Neurosurg 85:235\u2013242","journal-title":"Stereotact Funct Neurosurg"},{"key":"1819_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0090-3019(03)00048-X","volume":"59","author":"MJ McGirt","year":"2003","unstructured":"McGirt MJ, Villavicencio AT, Bulsara KR, Friedman AH (2003) MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surgical neurology 59:277\u2013281, discussion 281-282","journal-title":"Surgical neurology"},{"key":"1819_CR29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00701-003-0048-8","volume":"145","author":"JE Kim","year":"2003","unstructured":"Kim JE, Kim DG, Paek SH, Jung HW (2003) Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir (Wien) 145:547\u2013554, discussion 554-555","journal-title":"Acta Neurochir (Wien)"},{"key":"1819_CR30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1054\/jocn.1999.0226","volume":"7","author":"A Muacevic","year":"2000","unstructured":"Muacevic A, Uhl E, Steiger HJ, Reulen HJ (2000) Accuracy and clinical applicability of a passive marker based frameless neuronavigation system. J Clin Neurosci 7:414\u2013418","journal-title":"J Clin Neurosci"},{"key":"1819_CR31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00381-002-0644-6","volume":"18","author":"AM Messing-Junger","year":"2002","unstructured":"Messing-Junger AM, Floeth FW, Pauleit D, Reifenberger G, Willing R, G\u00e4rtner J, Coenen HH, Langen KJ (2002) Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas. Childs Nerv Syst 18:445\u2013449","journal-title":"Childs Nerv Syst"},{"key":"1819_CR32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2967\/jnumed.106.037895","volume":"48","author":"FW Floeth","year":"2007","unstructured":"Floeth FW, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider MJ, Jansen P, Coenen HH, Steiger HJ, Langen KJ (2007) Prognostic value of O-(2-18Ffluoroethyl)-L-tyrosine PET and MRI in low-grade glioma. J Nucl Med 48:519\u2013527","journal-title":"J Nucl Med"},{"key":"1819_CR33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2007-991143","volume":"50","author":"K Roessler","year":"2007","unstructured":"Roessler K, Gatterbauer B, Becherer A, Paul M, Kletter K, Prayer D, Hoeftberger R, Hainfellner J, Asenbaum S, Knosp E (2007) Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation. Minim Invasive Neurosurg 50:273\u2013280","journal-title":"Minim Invasive Neurosurg"},{"key":"1819_CR34","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s00259-005-0047-5","volume":"33","author":"B St\u00f6ber","year":"2006","unstructured":"St\u00f6ber B, Tanase U, Herz M, Seidl C, Schwaiger M, Senekowitsch-Schmidtke R (2006) Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F] fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging 33:932\u2013939","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1819_CR35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-008-9551-3","volume":"88","author":"F Stockhammer","year":"2008","unstructured":"Stockhammer F, Plotkin M, Amthauer H, van Landeghem FK, Woiciechowsky C (2008) Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas. J Neuro Oncol 88:205\u2013210","journal-title":"J Neuro Oncol"},{"key":"1819_CR36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3171\/jns.2003.99.3.0474","volume":"99","author":"T Hara","year":"2003","unstructured":"Hara T, Kondo T, Hara T, Kosaka N (2003) Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 99:474\u2013479","journal-title":"J Neurosurg"},{"key":"1819_CR37","first-page":"904","volume":"47","author":"W Chen","year":"2006","unstructured":"Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T (2006) 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47:904\u2013911","journal-title":"J Nucl Med"},{"key":"1819_CR38","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00259-003-1205-2","volume":"30","author":"B Beuthien-Baumann","year":"2003","unstructured":"Beuthien-Baumann B, Bredow J, Burchert W, F\u00fcchtner F, Bergmann R, Alheit HD, Reiss G, Hliscs R, Steinmeier R, Franke WG, Johannsen B, Kotzerke J (2003) 3-O-methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging. Eur J Nucl Med Mol Imaging 30:1004\u20131008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1819_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0969-8051(03)00121-5","volume":"31","author":"KJ Langen","year":"2004","unstructured":"Langen KJ, Jarosch M, Hamacher K, M\u00fchlensiepen H, Weber F, Floeth F, Pauleit D, Herzog H, Coenen HH (2004) Imaging of gliomas with cis-4-[18F]fluoro-L-proline. Nucl Med Biol 31:67\u201375","journal-title":"Nucl Med Biol"},{"key":"1819_CR40","first-page":"1948","volume":"46","author":"AH Jacobs","year":"2005","unstructured":"Jacobs AH, Thomas A, Kracht LW, Li H, Dittmar C, Garlip G, Galldiks N, Klein JC, Sobesky J, Hilker R, Vollmar S, Herholz K, Wienhard K, Heiss WD (2005) 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. J Nucl Med 46:1948\u20131958","journal-title":"J Nucl Med"},{"key":"1819_CR41","first-page":"2133","volume":"33","author":"PE Valk","year":"1992","unstructured":"Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF (1992) Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med 33:2133\u20132137","journal-title":"J Nucl Med"},{"key":"1819_CR42","first-page":"1151","volume":"46","author":"S Hemm","year":"2005","unstructured":"Hemm S, Rigau V, Chevalier J, Picot MC, Bauchet L, El Fertit H, Rodriguez MA, Cif L, Vayssi\u00e8re N, Zanca M, Baldet P, Segnarbieux F, Coubes P (2005) Stereotactic coregistration of 201Tl SPECT and MRI applied to brain tumor biopsies. J Nucl Med 46:1151\u20131157","journal-title":"J Nucl Med"},{"key":"1819_CR43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0212-6982(04)72312-5","volume":"23","author":"M Valle del","year":"2004","unstructured":"del Valle M, Torres MD, G\u00f3mez Rio M, Rodr\u00edguez Fern\u00e1ndez A, Sabatel Hernandez G, Ortega Lozano S, Ramos Font C, Bellon Guardia M, L\u00f3pez Ram\u00edrez E, Llamas Elvira JM (2004) Value of thallium 201-SPECT in typing brain space-occupying lesions. Rev Esp Med Nucl 23:330\u2013337","journal-title":"Rev Esp Med Nucl"},{"key":"1819_CR44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/jnnp.63.5.569","volume":"63","author":"K K\u00e4ll\u00e9n","year":"1997","unstructured":"K\u00e4ll\u00e9n K, Heiling M, Andersson AM, Brun A, Holt\u00e5s S, Ryding E, Ros\u00e9n I (1997) Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT. J Neurol Neurosurg Psychiatry 63:569\u2013574","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-010-1819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-010-1819-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-010-1819-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:54:51Z","timestamp":1559044491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-010-1819-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,3]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1007\/s00330-010-1819-2","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,3]]}}}